NEWS RELEASE | OCTOBER 17, 2017 Vancouver, BC — Augurex Life Sciences Corp is proud to announce that 14-3-3η, a novel rheumatoid arthritis (RA) biomarker, is paving a future for better patient outcomes. Today the U.S Patent and Trademark Office (USPTO) has issued...
